• FBB December 2018 – Newsletter

    December 2018 – Newsletter
     
    This month of December will beautifully close 2018 with 2 featured companies:
    Aspen Biosciences, who is launching a new comprehensive tool for a through exploration of the Biotech market, called Pharm2Market.
    And the in Vivo division of PerkinElmer, with the IVIS in vivo imaging systems and Quantum microCT imaging systems, which are best in class preclinical instruments for robust translational research.
     
    Companies of the month
     
    Aspen Biosciences
               
    PerkinElmer
     

     
    Résultats de recherche d'images pour « Perkinelmer »
     
    Aspen Biosciences – Pharm2Market

     
    Aspen Biosciences is a research informatics company which provides software and services to support drug discovery organizations. Some of our previous projects include custom target-, assay-, and compound-management systems designed to meet the unique needs of our customers. We also provide technology selection and implementation services for electronic lab notebook (eLN), and Lab Information Management Systems (LIMS). We have experience implementing systems to support a variety of therapeutic classes including small molecule, antibodies & peptides, and cell-based therapeutics.
     
    Pipeline – Drug Discovery Portfolio & Project Management
    Over the years we’ve had frequent requests for help developing or integrating project management tools. The challenge for most pharmaceutical companies has been that off-the-shelf applications in this space lack direct support for the science behind drug discovery projects. Tools like Microsoft Project, Jira, SmartSheet, and Asana lack support for target, pathway and literature information. They have no support for meeting and decision tracking, and lack support for lessons learned. To address that, we’ve distilled conversations with dozens of project and scientific portfolio managers in biotech and pharmaceutical companies into a cloud-based application called Pipeline.
     
    Pipeline helps drug discovery companies answer questions like, “What drug targets and pathways are we working on”, “What is their role in a given disease”, “What recent discoveries have been made (literature searching)”, “Who’s working on the project (project tracking & dashboarding)”, “What tasks are they performing”, “What’s the current status of the project”, “Where are the results from that cell-based assay we screened last month”, “How is this project similar to the project we worked on 5 years ago”, “What did we learn from this project”, “What lessons did we learn from previous projects that we can apply to this project”.

     
     
    Pharm2Market – Connecting Drug Discovery Communities
    Pharm2Market is a new service that we’re launching to connect drug discovery startups to news, investors, partners and services to help advance their drug discovery programs.
     
    If you’re a founder, Pharm2Market can help you find investors, partners and services in your area. We also help you find the resources, everything from finding legal advice on company formation and IP, to finding lab space, lab instrumentation and reagents. We also connect you with resources like the French Bio Beach, and San Diego Venture Group to help expand your network and keep track of all the local networking and conference opportunities.
     
    If you’re a business development professional, Pharm2Market contains information on over 200 local drug discovery companies. We track the projects, targets, therapeutic areas and therapeutic classes, pathways, and clinical trials that companies are involved in. This makes it easier for you to identify potential partnering and licensing opportunities.
     
    If your company provides lab space, construction or facilities services, you can use Pharm2Market to identify companies in need of expanded lab space, or lab remodels. If you provide contract research or manufacturing services, Pharm2Market can help you identify customers with Phase 2 and 3 projects who need your services in order to complete their clinical trials.
     

     
    To learn more about us or start a conversation, visit us on our web site, or reach out to us on social media:
     
    Twitter: @AspenBio @Pharm2Market
    Email: info@aspenbiosciences.com

     

     
    PerkinElmer In Vivo Imaging
     
    Image Caption: “IVIS Spectrum 3D bioluminescence reconstruction shows precise localization of GL261-luc2 brain tumor using digital organ map.”

    PerkinElmer Inc, through its Discovery & Analytical Solutions business segment, provides a suite of in vivo imaging solutions (IVIS) comprising reagents, software and instrumentation.  This powerful suite of tools allows researchers to visualize cellular and biological functions as well as anatomical and physiologic changes non-invasively in whole, live animals. 

    Optical imaging
    PerkinElmer’s IVIS instrument platform boasts several models each with somewhat different features and benefits and each designed to fit within almost any research budget.

    PerkinElmer’s flagship IVIS instrument is the IVIS Spectrum.  The Spectrum is the most advanced optical imaging system on the market combining high throughput (2D) optical imaging and full tomographic (3D) optical imaging in one platform.  The IVIS Spectrum is capable of ultra-sensitive bioluminescent and fluorescent imaging.  Bioluminescent sensitivity is achieved by using a cooled (-90ºC) camera with large CCD chip area and low F-stop.  With an exquisite signal-to-noise ratio (SNR) better than any other instrument on the market, the IVIS Spectrum has even been shown capable of detecting as few as five cells subcutaneously in nude mice.  For fluorescence applications, the IVIS Spectrum employs an optimized set of high efficiency filters (400nm to 900nm) and patented spectral unmixing software algorithms which grant researchers the ability to image and quantify all commonly used fluorophores, including fluorescent proteins, dyes and conjugates. 
    Going beyond just 2D imaging, full tomographic (3D) optical imaging can also be achieved with the IVIS Spectrum.  This allows researchers to analyze 3D sources in an anatomical context and quantify the of number of cells and/or the dye concentration.  Additionally, the 3D optical data can be co-registered with other tomographic technologies such as MR, PET or CT through PerkinElmer’s LivingImage multimodality software module.
     
    MicroCT Imaging
    Preserving the historical sweet spot of microCT imaging, PerkinElmer’s Quantum GX2, is an excellent imager for studying bone in exquisite detail.  But, thanks to its unique flat panel CMOS detector and its cardiac and respiratory gating tools, the Quantum GX2 also excels at providing functional information, such as cardiac function estimation or perfusion, as well as other soft tissue applications.
     
    Image Caption: “Quantum GX2 image of a mouse heart scanned using a four minute gated scan with CT contrast.”
     
    As previously mentioned, microCT has historically and primarily been used as a tool for capturing bone and skeletal image data, but bone data analysis was tedious and cumbersome.  To rectify this, scientists at PerkinElmer built AccuCT—a one-of-a-kind advanced, automated bone analysis software tool.  Designed to automatically segment bones and perform ASBMR morphometric analysis, AccuCT enables researchers at all levels of experience to perform advanced bone analysis in a user-friendly workflow-based software package.  In addition to facilitating data analysis, AccuCT’s 3D rendering capabilities produce high impact images for manuscripts and presentations with just a few mouse clicks. 
     
    Image Caption: “AccuCT from PerkinElmer automates bone identification, segmentation and analysis.”
     
    Through its advances in optical imaging and innovation with microCT imaging, PerkinElmer continues to open new doors for academic researchers and industry scientists alike.  Optical image data and microCT data can even be co-registered to better understand disease nuances in all its dimensions.
     
     
    To learn more about how in vivo imaging can help advance your research please contact your in vivo imaging specialist, Marc Guerra, at (619) 302-8405 or marc.guerra@perkinelmer.com

     
    Next Breakfast Event
     
    Because you are already sweet enough!
     
    Considering the significant increase of sugar consumption and commitments during the period of Christmas and New Year, the FBB committee board will hold on the Breakfast networking event until February.
     

     

     
    Happy Hour Networking Event
    bella vista social club & caffe
     
    December 14th
    from 5pm to 7pm (PST)
     
    Celebrating the end of the year. Come to tell us about your 2018 achievements and plan your 2019 expectations with a drink together.
     
     
     
     
     
    Social Activity
    Last chance to get your voice heard if you want to promote your favorite activities.
     
     
    First round of activity would open on Sunday, January 20, 2019 (10am-12pm).
    For now, six activities are leading the way: Hike, Surf, Pool (billiard), SUP/Kayak, Snorkeling, Tennis.

     

     
     
    Local News/Events
     
    Professional opportunities
    Antibody Design Labs is recruiting!
     
    We are looking for a part-time Office Assistant at our new location. The person will be in charge of diverse office clerk duties including helping with shipping and receiving, ordering and maintaining supply, managing files, recording information, greeting clients and visitors and coordinating team work and communication, among others. A strong organizational skill is welcome.
    Please send inquiry with resume at:  support@abdesignlabs.com
     
     
    We wish you happy holidays and hope to see you at our events!
    Kevin Adam, Beatrice David Shevlin and Stephane Richard of the French BioBeach team
    Follow our events and share to your friends/colleagues
     
             

     
    BECOME A
     
    OUR PARTNERS
     
    http://www.analytics-ventures.com/
     
     
     
     
     
     

     
    Thank You to our SPONSORS
    & MEMBERS
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Résultats de recherche d'images pour « Perkinelmer »
     
     
     
     
     
     
     

    Copyright © French BioBeach, All Rights Reserved.
     
    Business Platform, San Diego Area, California, United States
     
     
    Don't want this? Click here to unsubscribe.
     
     
     
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com
     
     
          
  • FBB November 2018 – Newsletter

    November 2018 – Newsletter
     
    After a month of October rich in networking events, November is following with the same momentum. Here are our news and activities for the upcoming month. In November our featured company is Cypre.
     
    Company of the month
    Cypre, Inc. has developed a simple 3D cell culture platform and tested protocols enabling scientists to assay complex tumor biology, including ex vivo (patient, PDX, mouse), tumor-stromal and tumor-immune coculture studies.

     

    VersaGel® is our proprietary, biocompatible 3D matrix that has the benefits of a hydrogel with the functional relevance of an extracellular matrix (ECM). Its design allows for cellular adhesion (through integrin binding sites, e.g. RGD), tumor and immune cell invasion, and MMP-degradation, mimicking the multiple phases of tumor progression.  VersaGel-Immunology is optimized for immune cell infiltration assays and VersaGel-Oncology, used in solid tumor assays, comes in three formulations for different growth conditions of various tumor cell types – Soft, Standard, Stiff. VersaGel is amenable to various methods of analysis, including high content imaging, plate reading, and flow cytometry following a 30-minute matrix digestion.
     
     
    Symphony® is our patented one-button instrument that solidifies VersaGel in microwell plates in 60 seconds. Symphony-24 and Symphony-96 are specifically designed for 24-well and 96-well plates respectively. Not much wider than a microtiter plate, the Symphony’s small footprint allows it to easily fit in your bio-safety cabinet further streamlining your workflow.
     
    Contact Robert Lynde (robert@cypre.co) to learn more about our demo program.
    Copyright© 2018 Cypre, Inc. All rights reserved.

     
    Next Breakfast Event
     
     
     

     

     

     
     
     
     
     
    Join us for a casual breakfast. This month Abbiotec will host the event. Abbiotec offers years of expertise making antibodies and assay kits for catalog products to the scientific and biotech community.
     
     
    When? Wednesday, November 7th
                from 8:00 to 9:30 am (PST)
     
    Where? 7985 Dunbrook Road,
    Suite A – San Diego, CA 92126
     

    Contact : (858) 586-0500  

     
    Happy Hour Networking Event
    bella vista social club & caffe https://ecp.yusercontent.com/mail?url=https%3A%2F%2Fcdn.evbuc.com%2Feventlogos%2F31248%2Fbellavista-2.jpg&t=1540866915&ymreqid=6ccb5610-53a0-1f6f-1c20-110001011c00&sig=unkBVS2esapgtA5MkKNLYg--~C
     
    November 9th
    from 5pm to 7pm (PST)
     
    Celebrating the Movember. Bring your most beautiful mustache to soak it in a drink together.
     
    All pattern are welcome!
     
     
     
     
    Social Activity
    Give us your opinion!
    The FBB community is growing and even if our common interests does not change, our way to interact can evolve. So let`s consider some activities together.
     
     
    Special Event
    Saturday, November 10th
     
    San Diego Fall Regatta 2018 – Sponsored by CureMatch
     
    If you wish to take advantage of this annual event to communicate/advertise about your company, we are currently open to distribute some goodies on the day of the event. Please contact the FBB Board of directors for any participation.
     
    Local News/Events
     
    We wish you a happy Halloween and hope to see you at our events!
    Kevin Adam, Beatrice David Shevlin and Stephane Richard of the French BioBeach team
    Follow our events and share to your friends/colleagues
     
             

     

     
    BECOME A
     
    OUR PARTNERS
     
    http://www.analytics-ventures.com/
     
     
     
     
     
     

     

     
    Thank You to our SPONSORS
    & MEMBERS
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    Résultats de recherche d'images pour « Perkinelmer »
     
     
     
     
     
     
     

     

    Copyright © French BioBeach, All Rights Reserved.
    Business Platform, San Diego Area, California, United States
     
    Don't want this? Click here to unsubscribe.
     
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com
     
          
     
  • FBB October 2018 – Newsletter

             
             French BioBeach October 2018 – Newsletter


    Our newsletter keeps you in the loop of FBB’s News & Events. If for any reason you would like to  
    You are welcome to join us again at a later time
     
    ~~ French BioBeach Breakfast ~~
     
     
    Start October with the traditional French BioBeach Breakfast sponsored jointly by ODEXXO! Network with Biotech professionals in a casual and warm atmosphere, while croissants and coffee will be graciously served:
      
    When?        Wednesday, October 3rd 2018 
                       from 8:00 to 9:30 am
     
    Where?      6450 Lusk Blvd, Suite E100
                       San Diego, CA 92121 
     
    Contact :    (858) 525-2318 
      
    About ODEXXO and its Founder
     
    ODEXXO Inc. designs proprietary portable devices for biological specimen collection and in-vitro diagnostic testing, based on immuno-chromatographic lateral-flow assays. The company’s All-in-One Platform offers optimal Ease-of-Use, Convenience and Safety.
    Physicians and Veterinarians around the world have relied on ODEXXO’s Technology to perform Multi-Disease Diagnosis within Minutes in challenging environments, such as at remote Point-of-Care, on the Farm or in the Field. 
    Phuong Nguyen, MBA, is the company’s Founder and CEO.  She has extensive experience launching novel products in the US and European markets, and continuously strives to bring innovations to serve the IVD community.
     
     

    Kevin Adam, Beatrice David Shevlin and Stephane Richard of the French BioBeach team, with Phuong Nguyen (CEO of ODEXXO) look forward to seeing you!
     
     
     
     
     
    Or just show up!
     
     
     
     
     
     
     

    ~~ French BioBeach Company of the month ~~ 

    ~PERKINELMER
    HIGH CONTENT IMAGING DIVISION~
     
      PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. Our dedicated team of about 11,000 employees worldwide is passionate about providing customers with an unmatched experience as they help solve critical issues especially impacting the diagnostics and discovery and analytical solutions markets.
     
    PerkinElmer’s comprehensive portfolio of technologies helps life sciences researchers better understand diseases and develop treatments.
    Scientists and clinicians can gain biological insights to improve outcomes through our discovery instruments and reagents, quantitative pathology platform, informatics software and lab services. 
    Our technologies and expertise have been instrumental in the development of 22 of the newest therapeutic drugs. 
     
    PerkinElmer’s Operetta CLS™ high-content analysis system enables scientists to uncover deep biological understanding from everyday assays and innovative applications. The system features a unique combination of technologies to deliver the speed, sensitivity and resolution needed to reveal fine subcellular details.
    The Opera Phenix™ high-content screening system is designed for high-throughput phenotypic screening and cellular analysis and is ideal for complex disease models such as live cells, primary cells and 3D cell culture models.
    Find out how PerkinElmer high-content analysis solutions allow robust and predictive discovery by visiting:

    Your West Coast High Content Imaging contact at PerkinElmer is Beatrice David Shevlin: beatrice.davidshevlin@perkinelmer.com
    858 603 2233
     
     
    ~~ French BioBeach Happy Hour ~~
     

     

     
    Monthly Happy Hour @ Bella Vista
       
    Join us for our Happy Hour! Let's enjoy a nice beer or a glass of wine (or both!) Come on! Let's get together:)
     
    We look forward to seeing you there…!
     
    When?    Friday, October 12th
                   from 5:00 to 7:00pm
     
     

     
    Free (no host bar)
    & open to all
    or just show up 🙂
     
    BECOME A
    Thank You to our  Partners
    http://www.analytics-ventures.com/
     
     
     
     
     
     

     

    Big Thank You to our Sponsors & Members
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
    French BioBeach
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com

             

  • FBB September 2018 – Newsletter

             
             French BioBeach September 2018 – Newsletter


    Our newsletter keeps you in the loop of FBB’s News & Events. If for any reason you would like to  
    You are welcome to join us again at a later time

    What`s going on at the FBB?

    Introduction of Kevin Adam, PhD and Beatrice David Shevlin, PhD, Co-directors of the French BioBeach business platform

    After Clementine Gibard beautifully took care of the French Biobeach activities and left for Idaho in January 2018, Stephane Richard is now working with two new team members, Kevin Adam, representing the more academic wing of the platform, and Beatrice David Shevlin, with industrial experience.


    BECOME A
    Thank You to our  Partners
    http://www.analytics-ventures.com/
     
     
     
     
     
     

     

    Kevin Adam, PhD

    Native from Brittany on the west coast of France, Kevin joined the warmer west coast of the US in September 2015. With over 7-years of experience in project management & research/development and over 2-years’ experience as consultant in competitive intelligence & market research, he joined the direction of the French BioBeach in 2018. Holder of a Master`s dual-degree in Oncology from the Ecole Normale Superieure of Cachan and a Magistere of Biotechnology from the Paris-Sud University (Paris XI), he earned his PhD in Onco-hematology from the Paris-Descartes University (Paris V) as a biologist.

    While doing his PhD, Kevin joined in 2012 the business incubator Quattrocento (5th French Tech investment) as a consultant in R&D strategy and innovation to satisfy his interest in innovation and industrialization. Then, he participated to the launch of the educational program Savanturiers in 2013, advertised later through the TEDx talk in Paris, to promote learning through experimenting and communication.

    Currently research associate at the Salk Institute, professional scientific collaborator at The Scripps Research Institute and consultant fellow at the APDCC of UCSD since 2016, he is now intending to expand the French BioBeach network and community. During the rest of his time, Kevin enjoys the outdoors activities offered by the Californian weather and he is fervent of backpacking adventures and travels.

     

    Beatrice David Shevlin, PhD

    Beatrice owns a double master’s degree in Organic Chemistry and Pharmacology, after completing the “Magistere Chimie-Biologie” at Louis Pasteur University, Strasbourg, France, and a PhD in Bio Organic Chemistry from Louis Pasteur University (January 1995), prepared under the supervision of Dr Francis Schuber.

    After a post doc at Kyoto University, Japan, she soon moved to business after earning a Purchasing Manager degree from IFOCOP Paris. She worked as a procurement associate for Clariant, in the Cuise-Lamotte factory, North of Paris.

    From 1999, Beatrice has been perfecting and selling scientific imaging platforms, to academic and industrial research laboratories, first with Hamamatsu Photonics France, then in 2004, she started and optimized the European branch of Xenogen Corporation, a San Francisco Bay based company that pioneered pre-clinical molecular imaging using bioluminescence and fluorescence. Xenogen Corporation was subsequently acquired by Caliper Life Sciences, which became part of PerkinElmer in 2011.

    In 2014 she moved to San Diego, and, after developing the sales of IVD devices in Europe for Acon Laboratories. She returned to PerkinElmer in January 2016 to become PerkinElmer High Content Imaging Senior Sales Specialist for the West Coast.

    Joining the French BioBeach is a natural move.

    Beatrice has been conducting business since 1999 in 4 different languages (French, English, Spanish and Italian), and has good knowledge of the Japanese culture.

    In parallel Beatrice is deeply involved in San Diego’s dancer’s community.


    Big Thank You to our Sponsors & Members
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     

    Come and meet the new team on September 14, at 5 PM, at the French BioBeach happy hour at the Bella Vista Caffe.

     


    Upcoming French BioBeach Events

    Monthly Happy Hour @ Bella Vista

     

     

     
    End of the week, Sunset & Happy Hour After Work? Let’s get together for our Monthly Networking Happy Hours. 
     
    We look forward to seeing you there…!
     
    When? Friday, September 14th, from 5:00 to 7:00pm

     Where?  Bella Vista Social Club & Caffe, 2880 Torrey Pines Scenic Dr, La Jolla, CA 92037 

     
     
    Look for our French BioBeach sign!
     
    Whether you would like to come debrief recent events or come discuss your latest startup project, the needs of your company (funding, advisors, people, CRO, IP attorney …), your latest scientific discovery (that you have of course already covered by a provisional), or just grab a TGIF drink and a glimpse of the sunset over the ocean with a bunch of international men & women of the San Diego biotech community, come join us at Bella V. .. and don’t worry, you don’t have to be French or speak French …
     
    Cheers 

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

     

    French BioBeach
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com

             

  • FBB November 2017 Newsletter





     
                 
                   
     
    Our newsletter keeps you in the loop of FBB’s News & Events. If for any reason you would like to  
    You are welcome to join us again at a later time
     
    BECOME A

     

     
    Thank You to our  Partners
     
     

    http://www.analytics-ventures.com/
     
     
     
     
     
     
     
     
     
     
     
     

     

    Big Thank You to our Sponsors & Members
     

     
     
     
     
     
     
     
     
     
     
     
     
     

     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     

     


     
    French BioBeach November 2017 Newsletter
     
       Dear French BioBeach community,
     
    After the success of the last month beakfast at Antibody Design, we are pleased to welcome you TOMORROW (Wednesday 1st) at ABBIOTEC jointly sponsored by ODDEXO. 
     
    To start this exciting newsletter we will present our FBB events with the traditional networking opportunities –> the Breakfast and the Happy Hour rendez-vous.
     
    Because to work hard we need to play hard sometimes, our new member SOMMAILLIER will present his concept of wine imported from France in the company of the month section, with an exclusive FBB discount just for you 🙂
     
    We end this newsletter by some events and news we thought you might enjoy!
     
    Thanks to your support, we continue to monitor what happens in the Life Sciences community fostering new Partnering and Business Opportunities.
    The French BioBeach Team  Cool
     
    Upcoming French BioBeach Events
     
     
    Coffee & Croissants
        
    The FBB Breakfast were traditionally on the first Tuesday of the month, but we thought that hump day will work even better!
    So from now on, you are welcome to join us on the first Wednesday of the month to share the yummy croissants and the much needed morning coffee 🙂
        
    When? Wednesday, November 1st from 8:00 am to 9.30 am

     

    Where?  Abbiotec  | 7985 Dunbrook Road | Ste A, San Diego | CA 92126

    abbiotec.com/contact/directions


     
     
     
     
     
     
     
     
     
     
    Monthly Happy Hour @ Bella Vista
     

    End of the week, Sunset & Happy Hour After Work? Let’s get together for our Monthly Networking Happy Hours. 
     
    We look forward to seeing you there…!

      
    When? Friday, November 10th, from 5:00 to 7:00pm

     

    Where?  Bella Vista Social Club & Caffe, 2880 Torrey Pines Scenic Dr, La Jolla, CA 92037 

    Look for our French BioBeach sign!

     

     
     
     
     
     
    Free (no host bar)
    & open to all
     
     

     
     
    or just show up 🙂

    Whether you would like to come debrief recent events or come discuss your latest startup project, the needs of your company (funding, advisors, people, CRO, IP attorney …), your latest scientific discovery (that you have of course already covered by a provisional), or just grab a TGIF drink and a glimpse of the sunset over the ocean with a bunch of international men & women of the San Diego biotech community, come join us at Bella V. .. and don’t worry, you don’t have to be French or speak French …

    Cheers 

     
     
    Company of the Month
     
     
    SOMMAILIER : a wine club created through 5 generations of French wine making experience
     
    For this month featured “company of the month”, we’d  like to introduce a newly created company here in San Diego,  SOMMAILIER! This is not yet another new microbrewery but   instead a brand new kind of boutique wine club 100% dedicated to French wines created by San Diego local and Bordeaux-native, Laurent Yung. He comes from five generations of French winemakers and has  access to exclusive, boutique French wines through his many connections in France. That’s the reason he started Sommailier – to share exclusive handcrafted wines that you can’t find in the U.S. with people who love French wine or want to learn more about it. Best part? The wine is shipped directly to your door every three months! And you can also send it as a gift to your wine lover friends or colleagues.Members will not only receive the bottles, but they will also receive education and information. Each bottle comes with a wine card providing information about the region it was grown and sourced, and the food pairing to accompany it. 
                                           
        
     
    Learn more about Sommailier and Laurent’s authentic story at www.sommailier.com. If you are interested in joining his club, you can use the code Biobeach20 and benefit from $20 off and free shipping on your first order. Feel free to contact him directly as well at laurent@sommailier.com if you have any question about his wine club.



      
     
     
     
    Events
     
     
     
    CRO Networking Mixer
    Please join on in the McGraw Boardroom at Biocom for a hosted CRO Networking Mixer specially designed for our CRO Members. With over a hundred CRO’s in our membership, this is an opportunity to gain a better understanding of your colleagues expertise in order to foster more collaboration within the CRO Community. 

    When?   November 7th 2017 5:00 pm to 7:00 pm
     
    Where? BIOCOM – McGraw Boardroom                            
    10996 Torreyana Road Suite 200
    San Diego, California  92121

     

    JLABS San Diego

    Meet with… Dementia Discovery Fund (DDF)
      
    Dementia is arguably the greatest single global healthcare challenge, affecting more than 47 million people worldwide at an estimated annual cost to the global economy of over US $604 billion…

    When? Tuesday, November 14th |
    10:30 AM to 5:00 PM
     
    Where? CONNECT
    4790 Eastgate Mall #125
     San Diego | California 92121       
           
     
     


                                                                                           
     
     

    BioLabs San Diego 

    “Bubbly and Blowouts”

     

    Join at the new drybar in La Jolla. This is a great event to network with other women in tech and biotech. Space is limited so book your spot and get your tickets.

     

    When?  Tuesday November 14th 2017

    4:00 PM – 7:00 PM


     

    Where?  Drybar La Jolla

    8867 Villa La Jolla Drive
    La Jolla, CA 92037                                

                        


                                           
     
    In the News
     
    • Thermo Fisher Scientific Signs Oncology Companion Diagnostic Development Agreement with Blueprint Medicines 
     
     
     
     
      MabVax Therapeutics Provides Update on the MVT-5873 Phase 1 Clinical Program and Expansion of Preclinical Development Pipeline at the AACR-NCI-EORTC International Conference
     
     
      Biotech Briefing: UC San Diego, Salk Scientists Awarded NIH Grants
     
     
     
     
     
    French BioBeach
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com

            

  • 2017 Oct, Featured Member of the month: APS





     
     
    Contact Information:
    Scott Barnhill,
    AS, SRS, RLATG
    Business Development Executive 
    American Preclinical Services, LLC
    8945 Evergreen Blvd.
    Minneapolis, MN 55433
    Main Phone:
    763-717-7990
    Direct Phone:
    763-951-8990
    Mobile:
    858-822-9648
    Direct Fax:
    763-951-8991
    sbarnhill@apsemail.com
    americanpreclinical.com

    The APS Preclinical Program:
    Your Path to Success 
     
    Finding a reliable partner in the preclinical CRO space can be challenging. In the early stages of product development, having a partner you can trust and rely on is of paramount importance.
    Welcome to American Preclinical Services. APS is an AAALAC and ISO17025 accredited, USDA registered and GLP compliant preclinical center of excellence located in Minneapolis, MN.

    At APS, we have developed a comprehensive Powerful Preclinical Program to assist companies in meeting their R&D goals. The APS Preclinical Program includes regulatory, biocompatibility, interventional medical device, surgical medical device, analytical, physician training, bioskills, pathology, pharmacology, and toxicology services. With this breadth of services under one roof, APS can advance your programs in all aspects of your product’s preclinical requirements. APS is adept at tailoring a Preclinical Program to fit your goals, with you and your team having direct collaborative control over study conduct and reporting timelines.
    Over 150 employees strong, the staff at APS have the scientific and technical expertise to guide your team in today’s fast paced and ever changing regulatory environment.  Whether you are conducting pilot evaluations, feasibility testing, or GLP studies, you will have industry experts to rely on every step of the way.
     

  • FBB october 2017 Newsletter





     
                 
                   
     
    Our newsletter keeps you in the loop of FBB’s News & Events. If for any reason you would like to  
    You are welcome to join us again at a later time
     
    BECOME A

     

     
    Thank You to our  Partners
     
     

    http://www.analytics-ventures.com/
     
     
     
     
     
     
     
     
     
     
     
     

     

    Big Thank You to our Sponsors & Members
     

     
     
     
     
     
     
     
     
     
     
     
     
     

     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     
     


     
    French BioBeach October 2017 Newsletter
     
    Dear French BioBeach community, 
     
    We have some great news for you… The FBB breakfast IS BACK! Thanks to our sponsor Antibody Design Labs you will have the opportunity to start this coming Tuesday with a delicious coffee and croissant 🙂
     
    This newsletter start with our FBB events. Our networking opportunities with our Breakfast and traditional Happy Hour rendez-vous.
     
    Then, our partner APL (American Preclinical Services) will be presented in the “Company of the Month” section. You will also find a link to apply for a Connected Intelligence Executive Circle organized by CLC.
     
    We end this exciting newsletter by some events and news we thought you might enjoy.
     
    Thanks to your support, we continue to monitor what happens in the Life Sciences community fostering new Partnering and Business Opportunities.
     
    The French BioBeach Team  Cool
     
    Upcoming French BioBeach Events
     
     
    Coffee & Croissants
     
    The FBB breakfast is back!!! 😀
       
    What’s best than a coffee and a croissant to start your tuesday properly?
        

    When? Tuesday October 3rd at 8:00am

     

    Where?  Antibody Design Labs
    Meeting in Coat-9, Conference center Union Station  –> Conference Room located next to “Come On In Cafe” @ 11120 Roselle St., Suite J San Diego, CA 92121

     

     Look for the French Flag…

     
     
     
     
     
     
     
     
     
    Monthly Happy Hour @ Bella Vista
     

    End of the week, Sunset & Happy Hour After Work? Join us for our Monthly (exeptionnaly the 3rd Friday of this month) Networking Happy Hours. 
     
    We look forward to seeing you there…!


    When? Friday, October 20th, from 5:00 to 7:00pm

     

    Where?  Bella Vista Social Club & Caffe, 2880 Torrey Pines Scenic Dr, La Jolla, CA 92037 

    Look for our French BioBeach sign!

     

     
     
     
     
     
    Free (no host bar)
    & open to all
     
     

     
     
     
    or just show up 🙂

    Whether you would like to come debrief recent events or come discuss your latest startup project, the needs of your company (funding, advisors, people, CRO, IP attorney …), your latest scientific discovery (that you have of course already covered by a provisional), or just grab a TGIF drink and a glimpse of the sunset over the ocean with a bunch of international men & women of the San Diego biotech community, come join us at Bella V. .. and don’t worry, you don’t have to be French or speak French …

    Cheers 

     
     
    Company of the Month
     
     
    The APS Preclinical Program: Your Path to Success

    Finding a reliable partner in the preclinical CRO space can be challenging. In the early stages of product development, having a partner you can trust and rely on is of paramount importance.
    Welcome to American Preclinical Services. APS is an AAALAC and ISO17025 accredited, USDA registered and GLP compliant preclinical center of excellence located in Minneapolis, MN.
    At APS, we have developed a comprehensive Powerful Preclinical Program to assist companies in meeting their R&D goals. The APS Preclinical Program includes regulatory, biocompatibility, interventional medical device, surgical medical device, analytical, physician training, bioskills, pathology, pharmacology, and toxicology services. 
     
    With this breadth of services under one roof, APS can advance your programs in all aspects of your product’s preclinical requirements. APS is adept at tailoring a Preclinical Program to fit your goals, with you and your team having direct collaborative control over study conduct and reporting timelines.

    Over 150 employees strong, the staff at APS have the scientific and technical expertise to guide your team in today’s fast paced and ever changing regulatory environment.  Whether you are conducting pilot evaluations, feasibility testing, or GLP studies, you will have industry experts to rely on every step of the way.
      
     
    Contact Information:
    Scott Barnhill, AS, SRS, RLATG 
    Business Development Executive 
    American Preclinical Services, LLC
    8945 Evergreen Blvd | Minneapolis, MN 55433
    Main Phone: 763-717-7990 | Direct Phone: 763-951-8990 | Mobile: 858-822-9648
    Direct Fax: 763-951-8991
    sbarnhill@apsemail.com
     
     
     
    Events
     
     
     
    CLC : 

    Connected Intelligence Executive Circle (SM)


    A virtual group coaching and networking experience like no other. By invitation or recommendation only


    All participants are sharp, supportive and interesting executives like you. Participants join each session via video conferencing from anywhere in the world, from any device, via private Zoom platform. 

    When?   Strating in October
     
    Where? video conferencing
     

    Confédération des Associations Centraliennes et Supelec
    Alumni Days Centrale(s) et Supélec 2017 à San Diego

    When? Thursday, July 20 2017 |

    4:00 pm – 7:00pm
    Where? Farmer & the Seahorse |
    10996 Torreyana Rd |
    San Diego, California 92121



     

                                                                                                             
     

    Charles River Presents : An Integrated Approach to Assess Drug-Induced Cardiovascular Liabilities

    Can we improve translation of preclinical data to clinical outcomes?


    Early in the drug development lifecycle, the process of evaluating compounds for hemodynamic and electrophysiological cardiovascular risk does not follow a regulated guideline, but more of an investigational method. Determining in-vitro assessments that translate to the whole animal and more importantly to the clinical outcome is paramount…

    When? 

    October 25, 2017 | 11:00 AM – 2:00 PM

     



    Where? 

    Green Acre | Campus Pointe 10300 Campus Point Drive | San Diego, CA 92121 Salon A


                                           
     
    In the News
     
     
    •  Drug from Sanford Burnham Prebys enters testing

     
     
     
    • International Stem Cell Corporation to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and Future Clinical Trials

       

     
     
     
    LaughingThank you for reading!!         
     
     
    French BioBeach
    Ph: +1 (858) 215-2462 • www.frenchbiobeach.com

            

  • Biocom in France: Part Deux

    Franco-American biotech ties flourish

    By Joe Panetta11:55 A.M.MAY 4, 2015

    panettaimage1a_r620x349

     

     

     

     

     

     

    San Diego delegation and PACA partners outside the offices of Innate Pharma. — Biocom

    (Editor's note: This is Part 2 of Biocom CEO Joe Panetta's return trip to southeastern France with a delegation from Biocom and French BioBeach, to strengthen the partnership between the region and Southern California. You can read Part 1 of the trip to Provence-Alpes-Côte d'Azur, or PACA, here)

    For two days since arriving here in Marseille to continue our Biocom and French BioBeach delegation trip, we have been awed by the growth of this life science cluster within the second largest city in France. We have visited clinical research hospitals and life science parks, an incubator and biotech companies including one that has been quite successful, as well as met with regional political and business leaders and potential partners.

    It has been a whirlwind two days in which our hosts and Biocom partners – Eurobiomed and the South Bio Alliance – have gone to extraordinary lengths to extend their hospitality and a unique perspective on all that this region can offer in the life sciences arena.

    We began yesterday with a visit to the Luminy campus of Marseille Immunopol, the subcluster for immunology in Marseille. It has unique positioning for immunology as a key technology here and has created an alliance that brings together all of its stakeholders within a collaborative ecosystem for innovation in immunology. The Immunopole includes hospitals, research institutes, academic labs and biotech companies.

    Marseille has a 40-year history of discovery and development in immunology beginning with Beckman Coulter Innotec which led to 60 spin-offs and other start-ups such as Innate Pharma, now a very successful company that we visited within the Immunopole. Innate has raised $185 million and has completed $1.8 billion in deals since 2006 including its most recent with AstraZeneca worth $250 million in initial payment with milestones worth up to $1.3 billion.

    A second company that we talked to was HalioDx, a spin-off of Qiagen Marseille that has a unique biomarker portfolio for use potentially by large pharma in developing companion diagnostics.

    Also within the Luminy Park is the Association Grand Luminy, the sole biotech incubator in the south of France which has operated since 1985. It has 2 missions: to sustain the local economy and to create and grow companies. Since 2009 Grand Luminy has also run a Biotech Nursery to host start ups from the incubator within a structure that includes support services, an entrepreneurship manager, strategic partnership development, patenting, communications management and corporate identity.

    To obtain a better understanding of the ability of the Marseille cluster to conduct clinical trials we visited AP-HM, the 3rd largest university hospital in France built on the concept of combining a high-technology hospital with research training. The hospital is now running more than 300 clinical trials.

    The day ended with expert presentations on human resources management, drug regulation in France and company financing at the 400-year old Palais de la Bourse, which is now home to our hosts for the afternoon and evening, the International Chamber of commerce of Marseille.

    The leaders of the Regional Council, Stephane Richard of French BioBeach and I exchanged greetings and addressed guests representing life science companies, the media and business leaders followed by a networking event held to welcome our delegation. While the event lasted well into the evening we knew that we could not end the day in this great city without once again sampling the remarkable bouillabaisse that is so expertly prepared within a few great establishments here, and at 10 PM in the evening we descended upon Le Rhul Restaurant. By midnight we were satiated and exhausted, and returned to our hotel.

    Today's schedule began even earlier in the morning with a visit to the IPC Paoli Calmettes cancer treatment center. It is one of a group of cancer treatment and research centers created by the great French President Charles de Gaulle after World War II, of which there are 20 in France.

    IPC Paoli is unique in that it includes a new unit called IPC Drug Discovery which works primarily in technologies that can detect blood levels of antibodies in an attempt to better identify weaknesses of cancer cells and DNA repair mechanisms. It also has a strong epigenetics group and a group working on metastasis. The unit is trying to find partners in pharma and biotech to conduct Phase I trials and to establish start up companies.

    Investment funding is available in Marseille as we learned in a presentation on PACA Investissmente, which sponsors a capital investment fund of 19.45 million Euro,managed by Thurenne Capital. Since its first investment in 2011, it has made investments in 38 companies and created 32 partnerships in the PACA region. To apply for funding a company must be early stage and incorporated in the region.

    This trip would not have been complete without a visit to NeuroService, a contract research firm located outside Marseille in Aix-en-Provence. The company has ties to San Diego as the region's first Biocom member firm here, and does 60 percent of its business in the US. NeuroService specializes in pharmacological assays based on electrophysiological recordings of acute brain and spinal cord slices, and cultured neurons to support early phases of CNS and pain R&D programs.

    Our second long day in the region ended with an informative tour of Aix-en-Provence city center and a farewell dinner with our most cordial hosts. It has been a truly incredible visit here from the standpoint of experiencing just how similar this area is to San Diego in its life science collaboration, diversity and innovation.

    A two-year gap in visiting our partners here perhaps provided a better perspective on their progress, but we talked over dinner about the opportunity to work together more closely in the future as the bridge we are building attracts more traffic.

    SOURCE: UT SAN DIEGO

  • French biotech: A return visit

    Biocom delegation travels to southeastern France for biotech

    By Joe Panetta12:05 P.M.

    Officials of San Diego's Biocom and Eurobiomed, an agency in southeastern Francce, sign an agreement to help biotech companies do business in each other's regions. From left, Magda Marquet, founder of Althea Technologies and chair of Biocom; Jacquie Berthe, president of Eurobiomed and a scientific director of Sanofi-Aventis; and Joe Panetta, president and CEO of Biocom.

    (Editor's note: Biocom, the San Diego-based life science trade group, has long cultivated ties with biotech in other nations. Biocom CEO Joe Panetta describes the group's latest mission, a return trip to France.)

    Two years ago I reported to U-T San Diego readers on the first trip by Biocom, French BioBeach and our members to Nice and Marseilles to explore partnership opportunities between life science clusters in the two regions of southern California and the Cotes d'Azur/Provence. That visit was eye-opening for all of us who participated, as we gained a great appreciation for the entrepreneurial environment and the long history of life science company formation and success, as well as the standout experience here is the conduct of clinical trials for oncology products.

    The relationship was furthered last year as representatives of both regions including Biocom, French BioBeach, and what is now known as the Provence-Alpes-Cote d'Azur South Bioalliance

    signed a formal partnership agreement during the BIO 2014 convention in San Diego.

    We returned to Nice and Marseilles in the spirit of our formal partnership this week with some past participants from San Diego, including Biocom Board Member and lead patent counsel at WSGR, Jeffrey Guise, Mike Honeysett of Acea and me, as well as new delegates such as the CEOs of Flow Paradigm, OncioMed, Abreos Biosciences (with one of his scientists) and CVAC Systems – a very inquisitive and engaged group who have asked probing questions of our hosts here while thus far expressing enthusiasm about what we have seen on the first part of our trip in Nice.

    Here's an update on the state of life science in this region in 2015 to provide a bit of perspective and comparison with southern California.

    The industry here is represented by 400 companies employing 10,000 people. Leading companies here include Beckman Coulter, Galderma, Sanofi-Aventis and Nicox. It is France's second largest center for clinical trials with 30,000 doctors and 39,000 hospital beds. It is a center of convergence of biotechnology, aquatic technologies, IT and wireless communications and tourism, and it has 6 universities including the largest in France in Marseilles (if this all sounds familiar it is because it is a mirror image of San Diego).

    Two years ago I reported that what struck me most about this region is its advanced experience in the field of clinical medicine. This was reinforced yesterday on our visits to the Centre Antoine Lacassagne, a regional cancer center that is close to completing a synchro-cyclotron proton therapy device that is the first of its kind in Europe, and to the national Alzheimer's pilot Institut Claude Pompidou for a presentation of some leading research projects of non-drug therapies to enhance cognitive function in patients through the use of IT-based solutions.

    The device at Lacassagne is one-fourth the weight of previous devices and uses 1/8 the electricity with a new dose administration technology called PBS – pencil beam scanning which is intensity- modulated to provide much higher "conformation" to tumor shape than past devices.

    We followed up with presentations by lead scientific researchers at the Institute of Biology Valrose within the University of Nice Sophia Antipolis, an international research center that addresses fundamental topics in developmental biology with links to associated diseases such as cancer, diabetes and obesity and utilizing various scientific approaches such as genetics, cell signaling and integrative physiology carried out on a wide range of model organisms.

    The impressive presentations on human adipose stem cells and obesity, on generation of functional beta cells from alternative pancreatic cell subtypes, on a flow cytometry iBV platform and on experimental histology in development and disease drew comments and questions by our group regarding the competitive nature of the work with what is being done in San Diego.

    Our long day ended with all of our companies making quick pitch presentations to an invited group of Nice life science company representatives at the Team Cote d'Azur office.

    Today (Tuesday) began with a legal presentation on doing business in France by the FIDAL law group ( the most popular question being whether it is actually possible to terminate an employee in France) followed by a day of visits to some of Nice's leading life science companies.

    Two that were of particular relevance to our San Diego group were Integra Life which is a device company based in New Jersey and producing brain catherization and mapping products here, and TxCell which is developing T cell immunotherapies for severe chronic inflammatory and autoimmune diseases such as Crohn's Disease. The latter drew questions from the entire group because the technology was an area of familiarity to many of our participants but even more so because all agreed that the research rivaled what they had seen in immunotherapy product development in San Diego.

    Another long day ended with our transfer to Marseilles and a late-evening reception hosted by the Eurbiomed-Provence Promotion Team. We'll spend the next two days here in Marseilles further examining the many potential opportunities for our southern California companies.

    SOURCE: UT SAN DIEGO

  • Biocom Annual Dinner Makes Waves | Innovation Night @ La Jolla Playhouse

    December Events FBB Attended

     

    Communique by Biocom on their annual dinner

    Sold-Out Biocom Annual Dinner Makes Waves

    The 2014 Biocom Annual Dinner, “Making Waves”, was definitely one for the ages. Many attendees of the sold-out event came away saying the program this year was one of the strongest ever. We thankall our sponsors for making this evening possible, especially Lead Sponsors BioMed Realty and VWR.

    The evening started with the popular networking reception, where old friendships were renewed and new relationships born. Retiring to the ballroom, the evening started off by a hearty greeting by Biocom Board Chair Magda Marquet and Biocom President and CEO Joe Panetta, followed by a “selfie” of the audience from the podium (available on Biocom’s Facebook page).

    City of San Diego Mayor Kevin Faulconer welcomed attendees and emphasized the importance of the life sciences to the region’s economy and to him personally. Congressman Scott Peters was then awarded Biocom’s “Elected Official of the Year,” becoming one of a very few policy makers who have won the award more than once. Due to votes in Washington DC, Congressman Peters accepted the award via video.

    Stephanie Venn-Watson, Director of the Translational Medicine and Research Program of the National Marine Mammal Foundation, described that organization’s work in Point Loma using dolphins in diabetes research. Dr. Venn-Watson pointed out that for purposes of diabetes research, dolphins are actually more similar to humans than rats or other mammals. Among its most exciting findings so far:dolphins have an “off switch” for some types of diabetes, giving hope that this research will lead to a similar finding in humans.

    The first portion of the evening closed with one of the most moving, powerful patient presentations ever given on a Biocom stage, as Sarah Wilson talked about her family’s challenges with two young children with Type I diabetes. She described the family’s specially trained dog, Ruby, who can detect dangerously low and high blood sugar by scent, and how Ruby likely saved her daughter’s life on the very first day of service by alerting the Wilsons to dangerous fluctuations in glucose readings overnight. And also how, after re-training the dog to track two members of the family, they realized this was aging the dog pre-maturely, and so now Sarah again wakes up every two hours during the night to test their blood sugars to give the dog recuperation time, lest they lose this valuable member of their team. Few who heard this family’s story will forget it.

    The keynote speaker was Dr. Rudy Tanzi, one of the world’s foremost Alzheimer’s researchers. Dr. Tanzi described how we got to where we currently are in our knowledge of Alzheimer’s: how it is believed that damage may start 15 years before any outward symptoms appear; the relationship between amyloid plaques, tangles, and manifestation of alzheimer’s, and the key and recurring role San Diego researchers and companies have played in advancing this knowledge.

    Dr. Tanzi talked about the difficulty in how Alzheimer’s has traditionally been modeled in animals (specifically, mice), in that it was not leading to discoveries that would effectively treat the disease. He hopes this will change with his team’s announcement last month that they had developed a method to create “Alzheimer’s in a dish,” human brain cells which manifest Alzheimer’s. This was accomplished by placing the cells in a gel, where they could develop neural networks similar to those found in the human brain. For the first time, researchers will be able to work with living human cells afflicted with Alzheimer’s. It is greatly hoped this breakthrough will accelerate research and effective treatments for Alzheimer’s. If a therapeutic cocktail can stop tangle development and the brain inflammation which is known to accompany Alzheimer’s development by “turning off” a physiological switch, it is hoped that an effective treatment for Alzheimer’s is possible.

    “Rock Star of Science,” Dr. Tanzi is also a passionate musician who has performed with Joe Perry of Aerosmith, among others. He closed his presentation by playing “Remember Me,” a beautiful, haunting song he wrote with Chris Mann, finalist on NBC’s “The Voice,” whose father is afflicted with Alzheimer’s. It is hoped this song will become an anthem to raise awareness about Alzheimer’s and give a voice to those patients and their loved ones. It will be in official release soon, we will keep you posted when it is available.

    Pictures from the event will be posted in the coming days on the Biocom Facebook page (please “like” us so you will see these in your facebook feed). Thank you to our members and their guests for sharing this most special of evenings with us, and to our sponsors for making it possible.

    The Wilson family visited Biocom member Dexcom, which makes some of the devices the children use.

    Biocom Board Chair Magda Marquet and Biocom President and CEO Joe Panetta

    San Diego Mayor Kevin Faulconer welcomes guests

    Congressman Scott Peters Accepts the Biocom 2014 Elected Official of the Year Award via video

    Charles McWilliams of VWR

    Stephanie Venn-Watson of the National Marine Mammal Foundation

    Patient Advocate Sarah Wilson speaks about the challenges of raising two Type I diabetic children

    R. Kent Griffin, Jr. of BioMed Realty Trust

    Keynote speaker Dr. Rudolph Tanzi

     

    SOURCE: BIOCOM